CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 136 enrolled
Drug / intervention
Trivalent, inactivated influenza vaccine (TIV) +2 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01827462
NCT01827462Phase 4Completed
CompareCT.gov

Immune Senescence in the Elderly: Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages

Stanford University·interventional·Posted Apr 9, 2013·Updated Jul 11, 2017

In Brief

A Phase 4 clinical trial evaluating Trivalent, inactivated influenza vaccine (TIV), Quadrivalent, inactivated influenza vaccine (IIV4), and 1 other intervention for Influenza. Completed, enrolled 136 participants across 1 site.

Detailed Summary

In this study the investigators are trying to understand how immune function declines in the elderly using annual influenza vaccinations as a model system. The longitudinal study began in 2007 and continued through early 2017.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza
CountriesUnited States
CollaboratorsNational Institute of Allergy and Infectious Diseases (NIAID)

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 9, 2013
Enrollment StartOct 1, 2007
Primary CompletionDec 1, 2015
Study CompletionMar 1, 2017
TodayJul 2, 2026
Enrollment to primary: 8.2 yearsPosted 13.2 years ago

Interventions

Trivalent, inactivated influenza vaccine (TIV)biological

Licensed Seasonal Influenza Vaccine TIV

Quadrivalent, inactivated influenza vaccine (IIV4)biological

Licensed Seasonal Influenza Vaccine IIV4

High-Dose Trivalent, inactivated influenza vaccine (TIV High-Dose)biological

Licensed Seasonal High-Dose Influenza Vaccine TIV